Literature DB >> 29342243

Devices in heart failure; diagnosis, detection and disease modification.

John Gierula1, Mark T Kearney1, Klaus K Witte1.   

Abstract

Introduction/background: Implantable cardiac devices are widely used in chronic heart failure (CHF) therapy. This review covers current CHF treatment with electronic cardiac devices, areas of discussion and emerging technologies. Sources of data: A comprehensive search of available literature resources including Pubmed, MEDLINE and EMBASE was performed. National and international guidelines were accessed. Areas of agreement: Excessive right ventricular pacing is detrimental to cardiac function. Cardiac resynchronization therapy is beneficial in specific individuals with CHF. Areas of controversy: Implantable cardioverter defibrillators might not benefit all. Optimizing CRT delivery. Remote monitoring seems not to be of benefit in CHF. Growing points: Device-based optimization. Areas timely for developing research: Personalization of device therapy. Focussing implantable cardioverter defibrillator therapy. What to do at implantable cardioverter defibrillator box change?

Entities:  

Mesh:

Year:  2018        PMID: 29342243      PMCID: PMC6410397          DOI: 10.1093/bmb/ldx051

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  62 in total

1.  Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion.

Authors:  Kevin Vernooy; Xander A A M Verbeek; Maaike Peschar; Harry J G M Crijns; Theo Arts; Richard N M Cornelussen; Frits W Prinzen
Journal:  Eur Heart J       Date:  2004-11-29       Impact factor: 29.983

2.  Mode of death in heart failure: findings from the ATLAS trial.

Authors:  P A Poole-Wilson; B F Uretsky; K Thygesen; J G F Cleland; B M Massie; L Rydén
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

3.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

Authors:  S J Connolly; A P Hallstrom; R Cappato; E B Schron; K H Kuck; D P Zipes; H L Greene; S Boczor; M Domanski; D Follmann; M Gent; R S Roberts
Journal:  Eur Heart J       Date:  2000-12       Impact factor: 29.983

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay.

Authors:  D A Kass; C H Chen; C Curry; M Talbot; R Berger; B Fetics; E Nevo
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

6.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group.

Authors:  A Auricchio; C Stellbrink; M Block; S Sack; J Vogt; P Bakker; H Klein; A Kramer; J Ding; R Salo; B Tockman; T Pochet; J Spinelli
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients.

Authors:  Hugues Bader; Stephane Garrigue; Stephane Lafitte; Sylvain Reuter; Pierre Jaïs; Michel Haïssaguerre; Jacques Bonnet; Jacques Clementy; Raymond Roudaut
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

9.  Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.

Authors:  Michael O Sweeney; Anne S Hellkamp; Kenneth A Ellenbogen; Arnold J Greenspon; Roger A Freedman; Kerry L Lee; Gervasio A Lamas
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

10.  The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population.

Authors:  Simon D R Thackray; Klaus K A Witte; Nikolay P Nikitin; Andrew L Clark; Gerald C Kaye; John G F Cleland
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

View more
  1 in total

1.  Assessing Communication during Remote Follow-Up of Users with Pacemakers in Norway: The NORDLAND Study, a Randomized Trial.

Authors:  Daniel Catalan-Matamoros; Antonio Lopez-Villegas; Knut Tore Lappegård; Remedios Lopez-Liria
Journal:  Int J Environ Res Public Health       Date:  2020-10-21       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.